Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA

@inproceedings{Gleason2014PreventionOM,
  title={Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA},
  author={Frank James Gleason and Renaud Chollet},
  year={2014}
}

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 201 CITATIONS, ESTIMATED 72% COVERAGE

Therapeutic Genome Editing in Cardiovascular Diseases

  • JACC. Basic to translational science
  • 2019
VIEW 11 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Exploring the potential of genome editing CRISPR-Cas9 technology.

VIEW 5 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

USING THE CRISPR / CAS 9 GENE EDITING TOOL TO DEVELOP A CURE FOR DUCHENNE MUSCULAR DYSTROPHY

Brendan Lettrich
  • 2017
VIEW 8 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Programmable Molecular Scissors: Applications of a New Tool for Genome Editing in Biotech

  • Molecular therapy. Nucleic acids
  • 2019
VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2014
2019

CITATION STATISTICS

  • 13 Highly Influenced Citations

  • Averaged 32 Citations per year from 2017 through 2019